PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN THE ACE INHIBITOR CILAZAPRIL AND BETA-ADRENOCEPTOR ANTAGONIST PROPRANOLOL IN HEALTHY-SUBJECTS AND IN HYPERTENSIVE PATIENTS

被引:7
作者
BELZ, GG
ESSIG, J
ERB, K
BREITHAUPT, K
HOOGKAMER, JFW
KNEER, J
KLEINBLOESEM, CH
机构
[1] ZE KA PHA GMBH,ZENTRUM KARDIOVASC PHARMAKOL,WIESBADEN,FED REP GER
[2] HOFFMANN LA ROCHE LTD,DEPT CLIN RES,BASEL,SWITZERLAND
关键词
D O I
10.1111/j.1365-2125.1989.tb03498.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S317 / S322
页数:6
相关论文
共 14 条
[11]   A METHOD FOR ESTIMATING THE POTENCY OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN MAN [J].
WELLSTEIN, A ;
ESSIG, J ;
BELZ, GG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (03) :397-399
[12]   INHIBITION OF ANGIOTENSIN-I RESPONSE BY CILAZAPRIL AND ITS TIME COURSE IN NORMAL VOLUNTEERS [J].
WELLSTEIN, A ;
ESSIG, J ;
BELZ, GG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (06) :639-644
[13]  
WELLSTEIN A, 1988, J PHARMACOL EXP THER, V246, P328
[14]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN ESSENTIAL-HYPERTENSION [J].
ZANCHETTI, A .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 :S2-S5